Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Type (2014-2025) 1.4.2 NGS Pre-Sequencing 1.4.3 Sequencing 1.4.4 NGS Data Analysis 1.4.5 Primary, Secondary & Tertiary Data Analysis 1.5 Market by Application 1.5.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2025) 1.5.2 Academic & Clinical Research 1.5.3 Hospitals & Clinics 1.5.4 Pharma & Biotech Entities 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size 2.2 Clinical Oncology Next Generation Sequencing (NGS) Growth Trends by Regions 2.2.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions (2014-2025) 2.2.2 Clinical Oncology Next Generation Sequencing (NGS) Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Manufacturers 3.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Manufacturers (2014-2019) 3.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Concentration Ratio (CR5 and HHI) 3.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players Head office and Area Served 3.3 Key Players Clinical Oncology Next Generation Sequencing (NGS) Product/Solution/Service 3.4 Date of Enter into Clinical Oncology Next Generation Sequencing (NGS) Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) 4.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) 5 United States 5.1 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019) 5.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in United States 5.3 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type 5.4 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application 6 Europe 6.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019) 6.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in Europe 6.3 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type 6.4 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application 7 China 7.1 China Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019) 7.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in China 7.3 China Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type 7.4 China Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application 8 Japan 8.1 Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019) 8.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in Japan 8.3 Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type 8.4 Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019) 9.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in Southeast Asia 9.3 Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type 9.4 Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application 10 India 10.1 India Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019) 10.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in India 10.3 India Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type 10.4 India Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application 11 Central & South America 11.1 Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019) 11.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in Central & South America 11.3 Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type 11.4 Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application 12 International Players Profiles 12.1 Illumina 12.1.1 Illumina Company Details 12.1.2 Company Description and Business Overview 12.1.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction 12.1.4 Illumina Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) 12.1.5 Illumina Recent Development 12.2 Roche 12.2.1 Roche Company Details 12.2.2 Company Description and Business Overview 12.2.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction 12.2.4 Roche Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) 12.2.5 Roche Recent Development 12.3 Agilent Technologies 12.3.1 Agilent Technologies Company Details 12.3.2 Company Description and Business Overview 12.3.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction 12.3.4 Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) 12.3.5 Agilent Technologies Recent Development 12.4 Knome 12.4.1 Knome Company Details 12.4.2 Company Description and Business Overview 12.4.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction 12.4.4 Knome Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) 12.4.5 Knome Recent Development 12.5 Genomatix Software 12.5.1 Genomatix Software Company Details 12.5.2 Company Description and Business Overview 12.5.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction 12.5.4 Genomatix Software Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) 12.5.5 Genomatix Software Recent Development 12.6 GATC Biotech 12.6.1 GATC Biotech Company Details 12.6.2 Company Description and Business Overview 12.6.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction 12.6.4 GATC Biotech Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) 12.6.5 GATC Biotech Recent Development 12.7 Oxford Nanopore Technologies 12.7.1 Oxford Nanopore Technologies Company Details 12.7.2 Company Description and Business Overview 12.7.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction 12.7.4 Oxford Nanopore Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) 12.7.5 Oxford Nanopore Technologies Recent Development 12.8 Macrogen 12.8.1 Macrogen Company Details 12.8.2 Company Description and Business Overview 12.8.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction 12.8.4 Macrogen Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) 12.8.5 Macrogen Recent Development 12.9 Life Technologies 12.9.1 Life Technologies Company Details 12.9.2 Company Description and Business Overview 12.9.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction 12.9.4 Life Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) 12.9.5 Life Technologies Recent Development 12.10 DNASTAR 12.10.1 DNASTAR Company Details 12.10.2 Company Description and Business Overview 12.10.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction 12.10.4 DNASTAR Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) 12.10.5 DNASTAR Recent Development 12.11 Exosome Diagnostics 12.12 Biomatters 12.13 CLC Bio 12.14 BGI 12.15 Qiagen 12.16 Perkin Elmer 12.17 Pacific Bioscience 12.18 Partek 12.19 GnuBIO 12.20 Foundation Medicine 12.21 Paradigm 12.22 Caris Life Sciences 12.23 Myriad Genetics 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Clinical Oncology Next Generation Sequencing (NGS) Key Market Segments Table Key Players Clinical Oncology Next Generation Sequencing (NGS) Covered Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type 2014-2025 Figure NGS Pre-Sequencing Figures Table Key Players of NGS Pre-Sequencing Figure Sequencing Figures Table Key Players of Sequencing Figure NGS Data Analysis Figures Table Key Players of NGS Data Analysis Figure Primary, Secondary & Tertiary Data Analysis Figures Table Key Players of Primary, Secondary & Tertiary Data Analysis Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth by Application 2014-2025 (Million US$) Figure Academic & Clinical Research Case Studies Figure Hospitals & Clinics Case Studies Figure Pharma & Biotech Entities Case Studies Figure Clinical Oncology Next Generation Sequencing (NGS) Report Years Considered Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2025 (Million US$) Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate 2014-2025 (Million US$) Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions 2014-2025 (Million US$) Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions 2014-2019 (Million US$) Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Regions 2014-2019 Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Regions 2014-2019 Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Regions 2019 Table Market Top Trends Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Manufacturers (2014-2019) (Million US$) Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Manufacturers (2014-2019) Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Manufacturers in 2018 Table Global Clinical Oncology Next Generation Sequencing (NGS) Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Clinical Oncology Next Generation Sequencing (NGS) Product/Solution/Service Table Date of Enter into Clinical Oncology Next Generation Sequencing (NGS) Market Table Mergers & Acquisitions, Expansion Plans Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$) Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Type (2014-2019) Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2014-2019) Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$) Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Application (2014-2019) Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2014-2019) Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Application in 2018 Figure United States Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$) Table United States Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$) Table United States Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019) Table United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$) Table United States Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019) Table United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$) Table United States Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019) Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$) Table Europe Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$) Table Europe Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019) Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$) Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019) Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$) Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019) Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$) Table China Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$) Table China Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019) Table China Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-20189) (Million US$) Table China Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019) Table China Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$) Table China Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019) Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$) Table Japan Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$) Table Japan Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019) Table Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$) Table Japan Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019) Table Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$) Table Japan Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019) Figure Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019) Table Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019) Table Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019) Figure India Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$) Table India Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$) Table India Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019) Table India Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$) Table India Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019) Table India Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$) Table India Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019) Figure Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$) Table Central & South America Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$) Table Central & South America Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019) Table Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$) Table Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019) Table Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$) Table Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019) Table Illumina Company Details Table Illumina Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) (Million US$) Figure Illumina Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) Table Illumina Recent Development Table Roche Company Details Table Roche Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$) Figure Roche Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) Table Roche Recent Development Table Agilent Technologies Company Details Table Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$) Figure Agilent Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) Table Agilent Technologies Recent Development Table Knome Company Details Table Knome Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$) Figure Knome Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) Table Knome Recent Development Table Genomatix Software Company Details Table Genomatix Software Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$) Figure Genomatix Software Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) Table Genomatix Software Recent Development Table GATC Biotech Company Details Table GATC Biotech Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$) Figure GATC Biotech Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) Table GATC Biotech Recent Development Table Oxford Nanopore Technologies Company Details Table Oxford Nanopore Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$) Figure Oxford Nanopore Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) Table Oxford Nanopore Technologies Recent Development Table Macrogen Company Details Table Macrogen Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$) Figure Macrogen Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) Table Macrogen Recent Development Table Life Technologies Company Details Table Life Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$) Figure Life Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) Table Life Technologies Recent Development Table DNASTAR Company Details Table DNASTAR Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$) Figure DNASTAR Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) Table DNASTAR Recent Development Table Exosome Diagnostics Company Details Table Biomatters Company Details Table CLC Bio Company Details Table BGI Company Details Table Qiagen Company Details Table Perkin Elmer Company Details Table Pacific Bioscience Company Details Table Partek Company Details Table GnuBIO Company Details Table Foundation Medicine Company Details Table Paradigm Company Details Table Caris Life Sciences Company Details Table Myriad Genetics Company Details Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions (Million US$) 2019-2025 Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Regions (2019-2025) Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Regions in 2025 Figure United States Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD) Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD) Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD) Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD) Figure India Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD) Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Product (2019-2025) (Million US$) Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Product (2019-2025) Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Product in 2025 Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2025) (Million US$) Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2025) Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Illumina Roche Agilent Technologies Knome Genomatix Software GATC Biotech Oxford Nanopore Technologies Macrogen Life Technologies DNASTAR Exosome Diagnostics Biomatters CLC Bio BGI Qiagen Perkin Elmer Pacific Bioscience Partek GnuBIO Foundation Medicine Paradigm Caris Life Sciences Myriad Genetics